Skip to search formSkip to main contentSkip to account menu

Toxic nephropathy

Known as: Kidney Toxicity, NEPHROPATHY TOXIC, TOXICITY RENAL 
Toxicity that impairs or damages the kidney. This condition is often caused by the administration of a pharmaceutical agent that causes damage to the… 
National Institutes of Health

Related topics

Related topics

8 relations
Acute Kidney Tubular NecrosisChronic inflammationDrug-induced NephropathyInterstitial tissue of kidney

Broader (3)

Kidney DiseasesNephrosisUrologic Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence.
Tenofovir (TDF) is an effective and widely used treatment for both human immunodeficiency virus (HIV) and hepatitis B virus… 
Highly Cited
2008
Highly Cited
2008
Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
Highly Cited
2007
Highly Cited
2007
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Highly Cited
2006
Highly Cited
2006
Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity.
Review
2006
Review
2006
Dosimetry in Peptide radionuclide receptor therapy: a review.
The potential of targeted therapy with radiolabeled peptides has been reported in several clinical trials. Although there have… 
Highly Cited
2005
Highly Cited
2005
Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.
UNLABELLED Nephrotoxicity is the major limiting factor during therapy with the radiolabeled somatostatin analog (90)Y-1,4,7,10… 
Review
2000
Review
2000
Safe levels of cadmium intake to prevent renal toxicity in human subjects.
The present review attempts to provide an update of the scientific knowledge on the renal toxicity which occurs in human subjects… 
Highly Cited
1994
Highly Cited
1994
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular…
PURPOSE This trial evaluated the toxicity and efficacy of high-dose carboplatin, etoposide, and ifosfamide followed by autologous… 
Highly Cited
1989
Highly Cited
1989
Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug.
Review
1979
Review
1979
The mechanism of action of antitumor platinum compounds.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)